Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLancashire Holdings Regulatory News (LRE)

Share Price Information for Lancashire Holdings (LRE)

Share Price is delayed by 15 minutes
Get Live Data
635.50    -3.50 (-0.55%)
Bid:
638.50
Ask:
639.00
Spread: 0.50 (0.078%)
Market Cap: £1.54b
LRE Live PriceLast checked at - London Stock Exchange

Intraday Lancashire Holdings Share Chart

Director/PDMR Shareholding

9 Mar 2011 18:46

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

1. Name of the issuer 2. State whether the notification

related to (i) a transaction Lancashire Holdings Limited notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance with LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006) (i)

3. Name of the person discharging 4. State whether notification

managerial responsibilities/ relates to a person connected director with a person discharging managerial responsibilities/ (1) Richard Brindle (Executive director named in 3 and identify Director) connected person (2) Neil McConachie (Executive N/A Director) (3) Alex Maloney (Executive Director) (4) Greg Lunn (PDMR)

5. Indicate whether the notification 6. Description of shares (including

is in respect of a holding of the class), debentures or derivatives person referred to in 3 or 4 or financial instruments relating above or in respect of a to shares non-beneficial interest N/A N/A

7. Name of registered shareholder(s) 8. State the nature of the

and, if more than one, the number transaction of shares held by each of them Grants of Restricted Share Awards N/A in the form of nil-cost options over the issuer's common shares pursuant to the issuer's Restricted Share Scheme rules, as amended by the issuer's shareholders on 22 December 2010. These grants have been made in connection with the issuer's bonus deferral plan. Vesting is subject to time and employment conditions only and there are no performance conditions. See further details in boxes 17 to 20.

9. Number of shares, debentures or 10. Percentage of issued class

financial instruments relating to acquired (treasury shares of the shares acquired class should not be taken into account when calculating N/A percentage) N/A

11. Number of shares, debentures or 12. Percentage of issued class

financial instruments relating to disposed (treasury shares of the shares disposed class should not be taken into account when calculating N/A percentage) N/A

13. Price per share or value of 14. Date and place of transaction transaction N/A N/A 15. Total holding following 16. Date issuer informed of

notification and total percentage transaction holding following notification (any treasury shares should not N/A be taken into account when calculating percentage) N/A

If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes

17. Date of grant 18. Period during which or date on which exercisable 4 March 2011 In accordance with the issuer's Restricted Share Scheme rules as amended by the issuer's shareholders on 22 December 2010, exercise of these bonus deferral Restricted Share Awards may occur on a date between 1 January 2013 and 4 March 2021.

19. Total amount paid (if any) for 20. Description of shares or

grant of the option debentures involved (class and number) Nil Restricted Share Awards under the Company's Restricted Share Scheme, structured as nil-cost options, granted over the issuer's common shares of US$0.50 each (1) Richard Brindle - 191,938 (2) Neil McConachie - 77,753 (3) Alex Maloney - 41,105 (4) Greg Lunn - 34,704

21. Exercise price (if fixed at time 22. Total number of shares or

of grant) or indication that debentures over which options price is to be fixed at the time held following notification of exercise Total number of Restricted Share Nil Awards granted under the issuer's Restricted Share Scheme and held following notification: (1) Richard Brindle - 259,161 (2) Neil McConachie - 113,415 (3) Alex Maloney - 41,105 (4) Greg Lunn - 45,686 These grants have been made in connection with the issuer's bonus deferral plan. Vesting is subject to time and employment conditions only and there are no performance conditions. Total number of Restricted Share Awards granted under the issuer's Restricted Share Scheme and held following notification: (1) Richard Brindle - 1,398,367 (2) Neil McConachie - 624,839 (3) Alex Maloney - 478,125 (4) Greg Lunn - 211,263 The actual number of shares to vest is dependent on the Rules of the Restricted Share Scheme including, inter alia, the satisfaction of applicable performance conditions. Total number of options granted under the issuer's Long Term Incentive Plan and held following notification: (1) Richard Brindle - 37,500 (2) Neil McConachie - 50,000 (3) Alex Maloney - 137,500 (4) Greg Lunn - 37,500 Total number of ordinary warrants held following notification: (1) Richard Brindle - 7,625,217 (2) Neil McConachie - 520,869 (4) Greg Lunn - 238,288 Total number of performance warrants held following notification: (1) Richard Brindle - 741,964 (2) Neil McConachie - 185,490 (4) Greg Lunn - 13,373 Total number of Founder warrants held following notification: Richard Brindle - 46,260

23. Any additional information 24. Name of contact and telephone

number for queries Christopher Head + 44 (0) 207 264 4145

Name of authorised official if issuer for making notification

Christopher Head Assistant Company Secretary 09 March 2011

vendor
Date   Source Headline
2nd Sep 20243:57 pmPRNDirector/PDMR Shareholding
9th Aug 20242:56 pmPRNDirector/PDMR Shareholding
8th Aug 20247:00 amPRNQ2 2024 Earnings Release
8th Aug 20247:00 amPRNNon-Executive Director Appointment
28th Jun 20244:31 pmPRNNotice of Results
28th May 20243:36 pmPRNHolding(s) in Company
16th May 202411:39 amPRNDirector/PDMR Shareholding
2nd May 20247:30 amPRNExecutive Director Appointment
2nd May 20247:30 amPRNResult of AGM
2nd May 20247:30 amPRNAppointment of Chair
2nd May 20247:00 amPRNQ1 Trading Statement
28th Mar 20244:45 pmPRNNotice of AGM
22nd Mar 20242:03 pmPRNDirector/PDMR Shareholding
21st Mar 20241:41 pmPRNNotice of Q1 2024 Trading Statement and Conference Call
19th Mar 20243:25 pmPRNDirector/PDMR Shareholding
15th Mar 20242:07 pmPRNDirector/PDMR Shareholding
13th Mar 20242:11 pmPRNDirector/PDMR Shareholding
13th Mar 20242:08 pmPRNDirector/PDMR Shareholding
6th Mar 20247:30 amPRNBoard Committee Changes
6th Mar 20247:00 amPRNFinal Results
30th Jan 20247:00 amPRNNotice of Q4 2023 Earnings Release and Conference Call
22nd Nov 20237:00 amPRNShare Repurchase Programme
9th Nov 20237:05 amPRNNon-Executive Director Appointment and Lancashire Board Chair Succession Planning
9th Nov 20237:00 amPRNQ3 Trading Statement
29th Sep 20234:30 pmPRNNotice of Results
25th Sep 20233:39 pmPRNDirector/PDMR Shareholding
11th Sep 20233:56 pmPRNHolding(s) in Company
10th Aug 20237:30 amPRNBoard Committee Changes
10th Aug 20237:00 amPRNQ2 2023 Earnings Release
7th Jul 20235:00 pmPRNNotice of Results
3rd Jul 20237:00 amPRNDirector/PDMR Shareholding
29th Jun 20231:10 pmPRNHolding(s) in Company
1st Jun 20224:08 pmPRNTotal Voting Rights
1st Jun 20227:00 amPRNTransaction in Own Shares
31st May 20227:00 amPRNTransaction in Own Shares
30th May 20227:00 amPRNTransaction in Own Shares
27th May 20227:00 amPRNTransaction in Own Shares
26th May 20227:00 amPRNTransaction in Own Shares
25th May 20227:00 amPRNTransaction in Own Shares
24th May 20227:00 amPRNTransaction in Own Shares
23rd May 202211:19 amPRNHolding(s) in Company
25th Mar 20227:00 amPRNNotice of Q1 2022 Trading Statement and Conference Call
15th Mar 20222:23 pmPRNDirector/PDMR Shareholding
15th Mar 20227:00 amPRNNotice of 2022 AGM and Publication of 2021 Annual Report
14th Mar 20227:00 amPRNDirector/PDMR Shareholding
11th Mar 20224:04 pmPRNHolding(s) in Company
1st Mar 20226:22 pmPRNHolding(s) in Company
24th Feb 20226:27 pmPRNDirector/PDMR Shareholding
24th Feb 20226:18 pmPRNDirector/PDMR Shareholding
16th Feb 20226:27 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.